Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 541 AL 555

GSK-3 Inhibitors: A New Class of Drugs for Alzheimer's Disease Treatment

Pal D, Mukherjee S, Song IH, Nimse SB.

Curr Drug Targets. 2021;22(15):1725-1737. doi: 10.2174/1389450122666210114095307.

Deep Brain Stimulation in Alzheimer's Disease: Targeting the Nucleus Basalis of Meynert

Chen YS, Shu K, Kang HC.

J Alzheimers Dis. 2021;80(1):53-70. doi: 10.3233/JAD-201141.

Recent Advances in the Discovery of GSK-3 Inhibitors from Synthetic Origin in the Treatment of Neurological Disorders

Saha S, Pal D, Nimse SB.

Curr Drug Targets. 2021;22(12):1437-1462. doi: 10.2174/1389450122666210120143953.

A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease

Lee JH, Kim HJ, Kim JU, Yook TH, Kim KH, Lee JY, Yang G.

Int J Mol Sci. 2021 Jan 28;22(3):1324. doi: 10.3390/ijms22031324.

Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia

Parsons C, Lim WY, Loy C, McGuinness B, Passmore P, Ward SA, Hughes C.

Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.

Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases

Ben-Shushan S, Miller Y.

J Phys Chem B. 2021 Mar 25;125(11):2796-2811. doi: 10.1021/acs.jpcb.0c11151. Epub 2021 Feb 11.

The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: From antioxidant to epigenetic therapy

Griñán-Ferré C, Bellver-Sanchis A, Izquierdo V, Corpas R, Roig-Soriano J, Chillón M, Andres-Lacueva C, Somogyvári M, Sőti C, Sanfeliu C, Pallàs M.

Ageing Res Rev. 2021 May;67:101271. doi: 10.1016/j.arr.2021.101271. Epub 2021 Feb 8.

A Scoping Review of Neuromodulation Techniques in Neurodegenerative Diseases: A Useful Tool for Clinical Practice?

Marson F, Lasaponara S, Cavallo M.

Medicina (Kaunas). 2021 Feb 27;57(3):215. doi: 10.3390/medicina57030215.

Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy

Nazam F, Shaikh S, Nazam N, Alshahrani AS, Hasan GM, Hassan MI.

Mol Cell Biochem. 2021 Jul;476(7):2739-2752. doi: 10.1007/s11010-021-04120-6. Epub 2021 Mar 9.

Mural Cells: Potential Therapeutic Targets to Bridge Cardiovascular Disease and Neurodegeneration

Lin A, Peiris NJ, Dhaliwal H, Hakim M, Li W, Ganesh S, Ramaswamy Y, Patel S, Misra A.

Cells. 2021 Mar 8;10(3):593. doi: 10.3390/cells10030593.

Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review

Łukasik P, Załuski M, Gutowska I.

Int J Mol Sci. 2021 Mar 13;22(6):2935. doi: 10.3390/ijms22062935.

Potential of Medicinal Plants as Neuroprotective and Therapeutic Properties Against Amyloid-β-Related Toxicity, and Glutamate-Induced Excitotoxicity in Human Neural Cells

Lobine D, Sadeer N, Jugreet S, Suroowan S, Keenoo BS, Imran M, Venugopala KN, Ibrahim FM, Zengin G, Mahomoodally MF.

Curr Neuropharmacol. 2021;19(9):1416-1441. doi: 10.2174/1570159X19666210412095251.

Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches

Cruz-Vicente P, Passarinha LA, Silvestre S, Gallardo E.

Molecules. 2021 Apr 11;26(8):2193. doi: 10.3390/molecules26082193.

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Vitalakumar D, Sharma A, Flora SJS.

J Biochem Mol Toxicol. 2021 Aug;35(8):e22830. doi: 10.1002/jbt.22830. Epub 2021 May 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias